This clinical guideline provides 3 key recommendations focused on defining the patient
population that should be considered for injectable opioid agonist treatment and outlining …

Background: Injectable opioid agonist treatment (iOAT) is an emerging evidence-based
option in the continuum of care for opioid use disorder in parts of Canada. Our study objective …

Permission has beer grarrred to the LIBRARY oF THE UNIVERSITY OF MANITOBA to lend
or sell copies of rhis tìresis, to the NATIONAL LIBRARY OF CANADA to microfilm this thesis …

We recognize that the ongoing criminalization, institutionalization, and discrimination
against people who use substances disproportionately harm Indigenous Peoples, and that …

Theories of memory consolidation have postulated that, according to the retention interval (ie
the number of years since the event), memory traces rely in part on different cerebral …

Primary pigmented nodular adrenocortical disease (PPNAD) is a cause of ACTH-independent
Cushing’s syndrome. This condition can be difficult to diagnose because hypercortisolism …

Rationale Antiepileptic drugs (AEDs) have been available for many years; yet, new members
of this class continue to be identified and developed due to the limitations of existing drugs, …

Structural stigma refers to the accumulated activities of organizations that create and
maintain social inequalities for people with lived and living experience of mental heath and …

Background Bipolar disorder is a recurrent illness that is amongst the top 30 causes of disability
worldwide and is associated with significant healthcare costs. In the past, emphasis was …

Background Fetal exposure to unmetabolized folic acid (UMFA) during pregnancy may be
associated with adverse neurodevelopment. Antiseizure medication (ASM) may interact with …